Literature DB >> 19184985

Hepatocyte growth factor induces hypoxia-related interleukin-8 expression in lung adenocarcinoma cells.

Yung-Yen Chiang1.   

Abstract

Rapid growth of cancer cells often creates insufficient supply of oxygen and nutrients in the tumour nest. The frequent detection of hypoxia-inducible factor (HIF) and interleukin-8 (IL-8) in afflicted tissues suggests that IL-8 expression could be associated with elevated levels of HIF. Recently, we found that hypoxia also upregulated the expression of hepatocyte growth factor (HGF) in lung adenocarcinoma (LAD) cells. However, the relationship between HGF and IL-8 has not been investigated in LAD cells. In this study, we found that HGF induced IL-8 expression in LAD. Interestingly, hypoxia also increased the level of prostaglandin F(2alpha) (PGF(2alpha)), a product of dihydrodiol dehydrogenase (DDH). When expression of DDH was suppressed by siRNA, the levels of PGF(2alpha), HGF and IL-8 were reduced; however, their levels returned to normal after DDH was reintroduced. These data suggest that hypoxia induces biosynthesis of PGF(2alpha), which then activates HGF and IL-8 expression. The results provide a reasonable explanation of how PGF(2alpha), HGF and IL-8 exert their effects on cancer cell metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184985     DOI: 10.1002/mc.20521

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

1.  Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer.

Authors:  Quynh-Thu Le; Richard Fisher; Kelly S Oliner; Richard J Young; Hongbin Cao; Christina Kong; Edward Graves; Rodney J Hicks; Grant A McArthur; Lester Peters; Brian O'Sullivan; Amato Giaccia; Danny Rischin
Journal:  Clin Cancer Res       Date:  2012-03-01       Impact factor: 12.531

Review 2.  Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation.

Authors:  Selma Rivas-Fuentes; Alfonso Salgado-Aguayo; Silvana Pertuz Belloso; Patricia Gorocica Rosete; Noé Alvarado-Vásquez; Guillermo Aquino-Jarquin
Journal:  J Cancer       Date:  2015-08-07       Impact factor: 4.207

Review 3.  Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?

Authors:  Xiangdong Wang; Ka Li; Hong Chen; Diane Wang; Yong Zhang; Chunxue Bai
Journal:  J Cell Mol Med       Date:  2010-01-30       Impact factor: 5.310

4.  Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown.

Authors:  R Srikar; Dhananjay Suresh; Ajit Zambre; Kristen Taylor; Sarah Chapman; Matthew Leevy; Anandhi Upendran; Raghuraman Kannan
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

Review 5.  The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.

Authors:  Jan Korbecki; Klaudyna Kojder; Patrycja Kapczuk; Patrycja Kupnicka; Barbara Gawrońska-Szklarz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

6.  Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma.

Authors:  Xiao Liang; Yali Chen; Yuchao Fan
Journal:  Environ Sci Pollut Res Int       Date:  2021-11-13       Impact factor: 5.190

7.  Secreted gelsolin desensitizes and induces apoptosis of infiltrated lymphocytes in prostate cancer.

Authors:  Chun-Chi Chen; Shiow-Her Chiou; Cheng-Lin Yang; Kuan-Chih Chow; Tze-Yi Lin; Hui-Wen Chang; Weir-Chiang You; Hisu-Wen Huang; Chien-Min Chen; Nien-Cheng Chen; Fen-Pi Chou; Ming-Chih Chou
Journal:  Oncotarget       Date:  2017-08-23

8.  Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 Diabetes.

Authors:  Andras Franko; Lucia Berti; Jörg Hennenlotter; Steffen Rausch; Marcus O Scharpf; Martin Hrabĕ de Angelis; Arnulf Stenzl; Andreas L Birkenfeld; Andreas Peter; Stefan Z Lutz; Hans-Ulrich Häring; Martin Heni
Journal:  J Pers Med       Date:  2020-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.